This country profile provides an overview of the Central African Republic’s progress in reaching those in need of mass NTD treatment based on 2017 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Download country profiles
Treatment coverage
Elephantiasis
NR Blinding trachoma
32% Intestinal worms
31% Bilharzia
NR River blindness
NR 0.82 million people received treatment in the Central African Republic in 2017 2.94 million people did not receive treatment in the Central African Republic in 2017
Priorities for progress in Central African Republic
- As a priority, the Central African Republic should submit the data on preventive chemotherapy (PC) coverage of bilharzia, river blindness and elephantiasis to WHO.
- Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.
Elephantiasis
Treatment coverage was 16% in 2016 and not reported in 2017.
People needing treatment
3.3m People receiving treatment
Not reported Blinding trachoma
Treatment coverage increased from 18% in 2016 to 32% in 2017.
People needing treatment
2.59m People receiving treatment
0.82m Intestinal worms
Treatment coverage decreased from 40% in 2016 to 31% in 2017.
Pre-sch and school-aged children needing treatment
1.76m Pre-school and school-aged children receiving treatment
0.55m Bilharzia
Treatment coverage was 66% in 2016 and not reported in 2017.
School-aged children needing treatment
0.57m School-aged children receiving treatment
Not reported River blindness
Treatment coverage was 50% in 2016 and not reported in 2017.
People needing treatment
2.49m People receiving treatment
Not reported The 
ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in the Central African Republic.